COLOPHON
About Online TB-500
A reading log on TB-500 and its parent thymosin beta-4 — a live transmission surfacing from the bathyal zone of the literature.
What this site is
Online TB-500 is a reading log for one fragment's evidence: the peer-reviewed research on TB-500 — the N-acetylated LKKTETQ heptapeptide fragment of thymosin beta-4 — surfaced study by study from the deep. No clinic operates at this depth, no clinicians are on staff, and no medical advice is transmitted; nothing is manufactured, supplied, or sold. What surfaces here is published science, logged and cited.
The site is structured as a reading log: each peer-reviewed finding is surfaced as a single specimen, cited to its source, and dated. The model is descent through a deep, mostly-empty literature — long stretches of quiet preclinical work punctuated by isolated points of light. The 1997 Malinda endothelial-chemotaxis paper. The 2004 Bock-Marquette Nature cardiac-repair paper. The 2023 RGN-259 neurotrophic-keratopathy Phase 3 result. The 2025 engineered tandem-Tβ4 corneal-healing work. Each surfaced as it is, with the citation visible.
The 'online' in the name
The 'online' modifier in onlinetb500.com is editorial framing. We use it in the sense of a live transmission — a remotely-operated reading log streaming up from the bathyal zone of the literature — not in the sense of an online store. The site sells nothing. It is a reading desk, not a vendor.
Editorial standards
Every quantitative claim on this site cites a peer-reviewed source. Doses, percentages, durations, half-lives, and effect sizes map to a numbered citation in the references index. The footer disclaimer is unique to this site; the editorial voice is consistent across all pages. We do not invent citations. We do not link to other portfolio domains. We do not write competitor trademarks. We do not provide dosing recommendations for humans.
What we do not do
No medical advice is issued here. No clinicians, pharmacists, or healthcare staff are aboard. TB-500, thymosin beta-4, and every related compound are things this site neither makes, supplies, nor ships. It endorses no human use of TB-500, and it runs no clinical service, no consultation, and no prescription pathway. Reading the published research and citing it is the entire scope of the log.